{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:01:44Z","timestamp":1779962504302,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00535-026-02351-2","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:40:35Z","timestamp":1770223235000},"page":"711-718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in adult eosinophilic esophagitis between Japan and Western countries"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1225-1785","authenticated-orcid":false,"given":"Yasuhiro","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinari","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhei","family":"Hosomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"2351_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1053\/j.gastro.2017.06.065","volume":"154","author":"KM O\u2019Shea","year":"2018","unstructured":"O\u2019Shea KM, Aceves SS, Dellon ES, et al. Pathophysiology of eosinophilic esophagitis. Gastroenterology. 2018;154:333\u201345.","journal-title":"Gastroenterology"},{"key":"2351_CR2","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1053\/j.gastro.2018.07.009","volume":"155","author":"ES Dellon","year":"2018","unstructured":"Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: Proceedings of the AGREE conference. Gastroenterology. 2018;155:1022\u201333.","journal-title":"Gastroenterology"},{"key":"2351_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14309\/ajg.0000000000003194","volume":"120","author":"ES Dellon","year":"2025","unstructured":"Dellon ES, Muir AB, Katzka DA, et al. ACG clinical guideline: Diagnosis and management of eosinophilic esophagitis. Am J Gastroenterol. 2025;120:31\u201359.","journal-title":"Am J Gastroenterol"},{"key":"2351_CR4","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1016\/j.cgh.2023.06.005","volume":"21","author":"JW Hahn","year":"2023","unstructured":"Hahn JW, Lee K, Shin JI, et al. Global incidence and prevalence of eosinophilic esophagitis, 1976\u20132022: A systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2023;21:3270\u201384.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2351_CR5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.14309\/ajg.0000000000001777","volume":"117","author":"AJ Bredenoord","year":"2022","unstructured":"Bredenoord AJ, Patel K, Schoepfer AM, et al. Disease burden and unmet need in eosinophilic esophagitis. Am J Gastroenterol. 2022;117:1231\u201341.","journal-title":"Am J Gastroenterol"},{"key":"2351_CR6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1053\/j.gastro.2017.06.067","volume":"154","author":"ES Dellon","year":"2018","unstructured":"Dellon ES, Hirano I. Epidemiology and natural history of eosinophilic esophagitis. Gastroenterology. 2018;154:319\u201332.","journal-title":"Gastroenterology"},{"key":"2351_CR7","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1016\/j.jaip.2021.06.026","volume":"9","author":"M Yamamoto","year":"2021","unstructured":"Yamamoto M, Nagashima S, Yamada Y, et al. Comparison of nonesophageal eosinophilic gastrointestinal disorders with eosinophilic esophagitis: A nationwide survey. J Allergy Clin Immunol Pract. 2021;9:3339\u201349.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2351_CR8","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/j.cgh.2024.04.035","volume":"22","author":"A Sawada","year":"2024","unstructured":"Sawada A, Imai T, Ihara Y, Tanaka F, Hirano I, Fujiwara Y. Epidemiology and risk factors of eosinophilic esophagitis in Japan: a population-based study. Clin Gastroenterol Hepatol. 2024;22:2023\u201332.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"suppl 1","key":"2351_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jgh.12746","volume":"30","author":"N Ishimura","year":"2015","unstructured":"Ishimura N, Shimura S, Jiao D, et al. Clinical features of eosinophilic esophagitis: Differences between Asian and Western populations. J Gastroenterol Hepatol. 2015;30(suppl 1):71\u20137.","journal-title":"J Gastroenterol Hepatol"},{"key":"2351_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/den.13786","volume":"33","author":"N Ishimura","year":"2021","unstructured":"Ishimura N, Okimoto E, Shibagaki K, et al. Similarity and difference in the characteristics of eosinophilic esophagitis between Western countries and Japan. Dig Endosc. 2021;33:708\u201319.","journal-title":"Dig Endosc"},{"key":"2351_CR11","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s00535-020-01701-y","volume":"55","author":"Y Fujiwara","year":"2020","unstructured":"Fujiwara Y. Symptom-based diagnostic approach for eosinophilic esophagitis. J Gastroenterol. 2020;55:833\u201345.","journal-title":"J Gastroenterol"},{"key":"2351_CR12","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1136\/gut.2006.107714","volume":"56","author":"J Ronkainen","year":"2007","unstructured":"Ronkainen J, Talley NJ, Aro P, et al. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: The population-based Kalixanda study. Gut. 2007;56:615\u201320.","journal-title":"Gut"},{"key":"2351_CR13","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1007\/s10620-014-3512-9","volume":"60","author":"X Ma","year":"2015","unstructured":"Ma X, Xu Q, Zheng Y, et al. Prevalence of esophageal eosinophilia and eosinophilic esophagitis in adults: a population-based endoscopic study in Shanghai, China. Dig Dis Sci. 2015;60:1716\u201323.","journal-title":"Dig Dis Sci"},{"key":"2351_CR14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1136\/gutjnl-2011-301817","volume":"62","author":"I Hirano","year":"2013","unstructured":"Hirano I, Moy N, Heckman MG, et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut. 2013;62:489\u201395.","journal-title":"Gut"},{"key":"2351_CR15","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1056\/NEJMra1502863","volume":"373","author":"GT Furuta","year":"2015","unstructured":"Furuta GT, Katzka DA. Eosinophilic esophagitis. N Engl J Med. 2015;373:1640\u20138.","journal-title":"N Engl J Med"},{"key":"2351_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4482","volume":"359","author":"JW Chen","year":"2017","unstructured":"Chen JW, Kao JY. Eosinophilic esophagitis: update on management and controversies. BMJ. 2017;359:j4482.","journal-title":"BMJ"},{"key":"2351_CR17","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1053\/j.gastro.2018.03.003","volume":"154","author":"E Odiase","year":"2018","unstructured":"Odiase E, Schwartz A, Souza RF, et al. New eosinophilic esophagitis concepts call for change in proton pump inhibitor management before diagnostic endoscopy. Gastroenterology. 2018;154:1217\u201321.","journal-title":"Gastroenterology"},{"key":"2351_CR18","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1002\/jgh3.12270","volume":"4","author":"F Ishibashi","year":"2019","unstructured":"Ishibashi F, Fukushima K, Onizuka R, et al. Risk of progression to eosinophilic esophagitis in patients with asymptomatic esophageal eosinophilia: a retrospective pilot study. JGH Open. 2019;4:422\u20138.","journal-title":"JGH Open"},{"key":"2351_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0206621","volume":"13","author":"H Sato","year":"2018","unstructured":"Sato H, Honma T, Nozawa Y, et al. Eosinophilic esophagitis in Japanese patients: a mild and slow-progressing disorder. PLoS ONE. 2018;13:e0206621.","journal-title":"PLoS ONE"},{"key":"2351_CR20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.cgh.2018.08.048","volume":"17","author":"N Ishimura","year":"2019","unstructured":"Ishimura N, Sumi S, Okada M, et al. Is asymptomatic esophageal eosinophilia the same disease entity as eosinophilic esophagitis? Clin Gastroenterol Hepatol. 2019;17:1405\u20137.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2351_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3164\/jcbn.20-49","volume":"68","author":"H Kitamura","year":"2021","unstructured":"Kitamura H, Tanaka F, Nadatani Y, et al. Eosinophilic esophagitis and asymptomatic esophageal eosinophilia display similar immunohistological profiles. J Clin Biochem Nutr. 2021;68:246\u201352.","journal-title":"J Clin Biochem Nutr"},{"key":"2351_CR22","doi-asserted-by":"publisher","first-page":"632","DOI":"10.5009\/gnl230398","volume":"18","author":"Y Suzuki","year":"2024","unstructured":"Suzuki Y, Ochiai Y, Kikuchi D, et al. Long-term outcome of asymptomatic esophageal eosinophilia. Gut Liver. 2024;18:632\u201341.","journal-title":"Gut Liver"},{"key":"2351_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10388-022-00967-w","volume":"20","author":"A Kanamori","year":"2023","unstructured":"Kanamori A, Tanaka F, Takashima S, et al. Esophageal mast cells may be associated with the perception of symptoms in patients with eosinophilic esophagitis. Esophagus. 2023;20:333\u201341.","journal-title":"Esophagus"},{"key":"2351_CR24","doi-asserted-by":"publisher","first-page":"E545","DOI":"10.1055\/a-2280-8277","volume":"12","author":"Y Abe","year":"2024","unstructured":"Abe Y, Kikuchi R, Sasaki Y, et al. Long-term course of untreated asymptomatic esophageal eosinophilia and minimally symptomatic eosinophilic esophagitis. Endosc Int Open. 2024;12:E545\u201353.","journal-title":"Endosc Int Open"},{"key":"2351_CR25","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1111\/all.16592","volume":"80","author":"K Osonoi","year":"2025","unstructured":"Osonoi K, Sawada A, Maekawa Y, et al. Involvement of IL-13-induced dysregulation of BDNF-NTRK2 pathway in symptoms of eosinophilic esophagitis. Allergy. 2025;80:2894\u20137.","journal-title":"Allergy"},{"key":"2351_CR26","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1056\/NEJMoa2313318","volume":"390","author":"ME Rothenberg","year":"2024","unstructured":"Rothenberg ME, Dellon ES, Collins MH, et al. Eosinophil depletion with Benralizumab for eosinophilic esophagitis. N Engl J Med. 2024;390:2252\u201363.","journal-title":"N Engl J Med"},{"key":"2351_CR27","first-page":"929","volume":"119","author":"Y Fujiwara","year":"2022","unstructured":"Fujiwara Y, Tanaka F, Nakata R, et al. Current real-world treatments for Japanese patients with eosinophilic esophagitis. Nihon Shokakibyo Gakkai Zasshi. 2022;119:929\u201336 ([in Japanese]).","journal-title":"Nihon Shokakibyo Gakkai Zasshi"},{"key":"2351_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-78868-4","volume":"14","author":"A Sawada","year":"2024","unstructured":"Sawada A, Ihara Y, Imai T, et al. Real world treatment patterns in patients with eosinophilic esophagitis in Japan. Sci Rep. 2024;14:27490.","journal-title":"Sci Rep"},{"key":"2351_CR29","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/gutjnl-2012-302250","volume":"62","author":"E Cheng","year":"2013","unstructured":"Cheng E, Zhang X, Huo X, et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD. Gut. 2013;62:824\u201332.","journal-title":"Gut"},{"key":"2351_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050037","volume":"7","author":"X Zhang","year":"2012","unstructured":"Zhang X, Cheng E, Huo X, et al. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells. PLoS ONE. 2012;7:e50037.","journal-title":"PLoS ONE"},{"key":"2351_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.2147\/JAA.S274524","volume":"15","author":"JP Franciosi","year":"2022","unstructured":"Franciosi JP, Mougey EB, Dellon ES, et al. Proton pump inhibitor therapy for eosinophilic esophagitis: History, mechanisms, efficacy, and future directions. J Asthma Allergy. 2022;15:281\u2013302.","journal-title":"J Asthma Allergy"},{"key":"2351_CR32","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/apt.13325","volume":"42","author":"Y Sakurai","year":"2015","unstructured":"Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects\u2014a randomised open-label cross-over study. Aliment Pharmacol Ther. 2015;42:719\u201330.","journal-title":"Aliment Pharmacol Ther"},{"key":"2351_CR33","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/apt.15641","volume":"51","author":"T Takeuchi","year":"2020","unstructured":"Takeuchi T, Furuta T, Fujiwara Y, et al. Randomised trial of acid inhibition by vonoprazan 10\/20 mg once daily vs rabeprazole 10\/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study). Aliment Pharmacol Ther. 2020;51:534\u201343.","journal-title":"Aliment Pharmacol Ther"},{"key":"2351_CR34","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1053\/j.gastro.2021.02.016","volume":"160","author":"E Odiase","year":"2021","unstructured":"Odiase E, Zhang X, Chang Y, et al. In esophageal squamous cells from eosinophilic esophagitis patients, Th2 cytokines increase eotaxin-3 secretion through effects on intracellular calcium and a non-gastric proton pump. Gastroenterology. 2021;160:2072\u201388.","journal-title":"Gastroenterology"},{"key":"2351_CR35","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s10388-020-00783-0","volume":"18","author":"T Kuzumoto","year":"2021","unstructured":"Kuzumoto T, Tanaka F, Sawada A, et al. Vonoprazan shows efficacy similar to that of proton pump inhibitors with respect to symptomatic, endoscopic, and histological responses in patients with eosinophilic esophagitis. Esophagus. 2021;18:372\u20139.","journal-title":"Esophagus"},{"key":"2351_CR36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1097\/MCG.0000000000001869","volume":"58","author":"Y Fujiwara","year":"2024","unstructured":"Fujiwara Y, Sawada A, Ominami M, et al. Responses of proton pump inhibitors and potassium-competitive acid blockers according to outcomes of symptom, endoscopy, and histology in patients with eosinophilic esophagitis. J Clin Gastroenterol. 2024;58:337\u201341.","journal-title":"J Clin Gastroenterol"},{"key":"2351_CR37","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/j.cgh.2025.01.016","volume":"23","author":"AJ Lucendo","year":"2025","unstructured":"Lucendo AJ, Guti\u00e9rrez-Ram\u00edrez L, Tejera-Mu\u00f1oz A, et al. Proton pump inhibitors for inducing and maintaining remission in eosinophilic esophagitis: An updated systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2025;23:2115\u201327.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2351_CR38","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1016\/j.cgh.2023.04.028","volume":"21","author":"AY Lam","year":"2023","unstructured":"Lam AY, Lee JK, Coward S, et al. Epidemiologic burden and projections for eosinophilic esophagitis\u2013associated emergency department visits in the United States: 2009-2030. Clin Gastroenterol Hepatol. 2023;21:3041-3050.e3.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2351_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.cgh.2021.04.022","volume":"20","author":"I Hirano","year":"2022","unstructured":"Hirano I, Collins MH, Katzka DA, et al. Budesonide oral suspension improves outcomes in patients with eosinophilic esophagitis: Results from a Phase 3 trial. Clin Gastroenterol Hepatol. 2022;20:525\u201334.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2351_CR40","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1056\/NEJMoa2205982","volume":"387","author":"ES Dellon","year":"2022","unstructured":"Dellon ES, Rothenberg ME, Collins MH, et al. Dupilumab in adults and adolescents with eosinophilic esophagitis. N Engl J Med. 2022;387:2317\u201330.","journal-title":"N Engl J Med"},{"key":"2351_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.alit.2015.03.002","volume":"64","author":"T Shoda","year":"2015","unstructured":"Shoda T, Morita H, Nomura I, et al. Comparison of gene expression profiles in eosinophilic esophagitis (EoE) between Japan and Western countries. Allergol Int. 2015;64:260\u20135.","journal-title":"Allergol Int"},{"key":"2351_CR42","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1053\/j.gastro.2019.09.052","volume":"158","author":"I Hirano","year":"2020","unstructured":"Hirano I, Furuta GT. Approaches and challenges to management of pediatric and adult patients with eosinophilic esophagitis. Gastroenterology. 2020;158:840\u201351.","journal-title":"Gastroenterology"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-026-02351-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-026-02351-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T09:03:16Z","timestamp":1779958996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-026-02351-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["2351"],"URL":"https:\/\/doi.org\/10.1007\/s00535-026-02351-2","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,4]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Y.F. has received speaker fees from Takeda, Otsuka, Astellas, AstraZeneca, and research grant from EA Pharma. A.S., F.T declare no conflict of interest. S.H. received lecture fees from Takeda and AbbVie.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to reproduce material from other sources"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}]}}